Tower Research Capital LLC (TRC) - ONCOGENEX PHARMACEUTICALS IN ownership

ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 68 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is 38.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2015$0
-100.0%
400
-65.6%
0.00%
-100.0%
Q2 2014$4,000
-77.8%
1,163
-23.0%
0.00%
-50.0%
Q1 2014$18,000
+80.0%
1,511
+24.9%
0.00%0.0%
Q4 2013$10,000
-44.4%
1,210
-38.0%
0.00%0.0%
Q3 2013$18,000
-61.7%
1,951
-59.0%
0.00%
-50.0%
Q2 2013$47,0004,7570.00%
Other shareholders

There were no reported owners of ONCOGENEX PHARMACEUTICALS IN in Q4 2013.

NameSharesValueWeighting ↓
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders